📖 Approx. 6 min
In business succession and M&A of non-equity medical corporations (fund-contributing type), the timing for returning the “fund” contributed by the founder and its tax treatment are extremely critical issues that directly impact the net funds retained by the contributor and the financial health of the medical corporation. This article provides a professional overview of the requirements for medical corporations to properly return contributed funds, the tax treatment, and the relationship with member changes, enterprise tax, and various regulatory approvals associated with M&A.
Basic Structure of the Fund Contribution System in Medical Corporations (Non-Equity / Fund-Contributing Type)
Among non-equity medical corporations under the Medical Care Act (revised Medical Care Act enacted in April 2007), a “fund-contributing medical corporation” treats funds contributed by members and others upon establishment or reorganization as a “fund.” This is similar to the fund system in general incorporated associations and foundations, functioning with characteristics similar to equity/owned capital while also possessing liability-like aspects where repayment is obligated in the future.
In the case of medical corporations with equity shares (transitional medical corporations), share transfers or refunds of equity associated with retirement often trigger significant tax risks (such as deemed dividend taxation) and cash outflow risks. On the other hand, in fund-contributing medical corporations, the returned amount is limited to the “contributed amount (principal),” and the distribution of interest or surplus profits is prohibited under Article 54 of the Medical Care Act.
Because a fund has the property of “being returned within the limit of the contributed amount,” its evaluated value does not swell with the expansion of the corporation’s net assets as it does in medical corporations with equity shares. However, strict statutory requirements exist for return procedures and tax treatment.
Necessity of Fund Return and Timing of Decision-Making in Medical M&A and Business Succession
When conducting business succession or M&A (third-party succession) of a medical corporation, the timing of returning funds previously contributed by the retiring founder (former board chairman, etc.) significantly impacts financial planning and post-succession operational structure. In general practice, fund returns are considered alongside member changes or board chairman transitions, or as part of prior financial restructuring.
If the timing of the return is mismanaged, there is a risk of insufficient working capital after succession, or hindrance to funding for facility and equipment upgrades tailored to regional medical needs (such as bed reorganizations stemming from the Regional Medical Vision or responses to medical fee revisions).
Fund returns are decided via resolutions at the regular general meeting of members. Therefore, incorporating the timing of fiscal year-ends and member meeting schedules before and after signing the final agreement (DA) in an M&A is the key to a smooth succession.
Specific Tax Treatment and Handling of Corporate/Income Taxes Surrounding Fund Returns
In terms of tax law, the return of a fund has characteristics extremely close to the “repayment of borrowings.” As long as the amount returned to the individual contributor equals the original contributed amount, it is not subject to income tax such as employment income, dividend income, or capital gains tax, allowing recovery on a tax-free basis in principle.
On the other hand, regarding accounting and tax treatment on the medical corporation side, building a reserve for fund returns is required. In the financial closing of the fiscal year in which the return is made, a “reserve for fund returns” in the amount equal to the returned fund must be recognized under the net assets section.
| Category | Tax Treatment for Contributor (Individual) | Accounting & Tax Treatment for Medical Corporation |
|---|---|---|
| Return equal to contributed amount | Tax-free (recovery of principal) | Recognition of reserve for fund returns (non-deductible expense) |
| Return less than contributed amount (partial waiver, etc.) | Miscellaneous loss or donation/charitable contribution (requires individual assessment) | Recognition of gain on debt cancellation (taxable income) |
| Return exceeding contributed amount | Prohibited under the Medical Care Act (cannot be executed) | Violation of Article 54 of the Medical Care Act |
Note that if the contributor waives part or all of their claim for fund return due to significantly deteriorated financial conditions, debt forgiveness income will occur on the medical corporation’s side, which may be subject to corporate taxation (or offset against expired net operating losses), requiring cautious consideration (consultation with a tax accountant is recommended as treatment varies by case). Furthermore, attention must be paid to the treatment of size-based enterprise taxation and special local corporate enterprise tax.
Legal Flow and Required Documents in Medical Corporation Fund Return Procedures
To return funds, a medical corporation must meet strict legal requirements based on mutatis mutandis application of the Act on General Incorporated Associations and General Incorporated Foundations. Voluntary returns on an ad-hoc basis are not permitted, and failure to follow procedures may render the return invalid or subject directors to non-penal fines.
- Resolution at Regular General Meeting of Members: The total return amount for a given fiscal year is determined with approval from the regular general meeting of members.
- Calculation of Distributable Return Amount: The “required net asset amount” calculated by deducting capital, funds, and certain legal reserves from net assets on the balance sheet is determined to verify the upper limit available for return.
- Creditor Protection Procedures (Public Notice & Individual Notice): Publication in the Official Gazette (Kampo) for at least one month and individual notices to known creditors are conducted to secure opportunities for raising objections.
- Recognition of Reserve for Fund Returns: An amount equivalent to the returned amount is transferred from retained earnings to the reserve for fund returns.
- Execution of Return: Once all requirements are fulfilled, funds are remitted and returned to the contributor’s designated bank account or through other specified means.
Generally, this legal process requires at least 2 to 3 months. Schedule adjustment working backward from the execution date of the M&A or business succession is essential.
Financial Risks During Fund Return and Impact on Medical Fee Revisions and Facility Standards
Since fund returns involve cash outflows from the medical corporation, careful consideration must be given to the post-execution impact on cash flow and financial metrics. In particular, making a massive fund return during periods preceding medical fee revisions or facility investments needed to meet regional facility standards increases the risk of temporary liquidity shortages.
For example, cases arise where introducing new medical equipment or renovating hospital beds is necessary to maintain facility standards or transition functions under the Regional Medical Vision. If cash reserves decrease excessively due to fund returns, terms for additional loans from financial institutions may tighten, potentially hindering the operation of the medical institution.
In addition, depending on the scale and profit/loss status of the medical corporation, trends show cases where adjustments to the return schedule are made in advance with prospective buyers or the acquiring group, incorporating gradual returns or relaxed return conditions into contracts as creative measures.
Pre-Checkpoints for Fund-Contributing Medical Corporations Aiming for Successful Succession & M&A
To smoothly proceed with medical M&A or intra-family succession, organizing various information related to funds prior to the transfer or succession is extremely important. Utilizing the following pre-check list to verify legal and financial aspects for potential issues is recommended.
✅ Pre-Verification Checklist for Fund Return
- ✅ Are the fund contribution contract, receipt, and transfer slip from the time of contribution preserved?
- ✅ Are there clear resolution records regarding fund contributions in past general meeting minutes?
- ✅ Does the net asset amount on the balance sheet satisfy the requirements for return (distributable return amount)?
- ✅ Has the return timing been agreed upon between retiring officers (founders, etc.) and the new post-succession management team?
- ✅ Have schedule adjustments been completed if permit/license applications or prefectural approvals for articles of incorporation amendments are required?
- ✅ Will sufficient cash remain on hand for post-succession working capital, medical fee revisions, and maintenance of facility standards?
Because fund returns and business succession procedures in medical corporations involve complex interactions among the Medical Care Act, tax law, and accounting standards, decisions tailored to specific individual circumstances (such as corporate net asset values and succession schemes) are indispensable. CentralMedience Co., Ltd. / M&A Medical, as an M&A support organization certified by the Small and Medium Enterprise Agency, provides specialized consulting for business succession and M&A based on medical industry expertise. Board chairpersons and owners concerned about fund return timing or tax and legal procedures are encouraged to take advantage of our free consultation.
Consult M&A Medical for Healthcare Succession
M&A Medical is a specialized M&A and business succession support service for medical institutions. As an M&A support organization certified by the Small and Medium Enterprise Agency, we support everything from the transfer of clinics and medical corporations struggling with successor shortages to strategic acquisitions on a success-fee basis.
- Free initial consultation and simplified valuation
- ¥0 retainer fee and monthly fee (success fee only)
- Strict confidentiality (proceeds under NDA)
- Nationwide coverage across all 47 prefectures and all medical specialties
Whether you just want to know market valuations, have no successor, or are considering joining a group, please consult us early in your evaluation phase.